GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » EBITDA Margin %

Bionoid Pharma (Bionoid Pharma) EBITDA Margin % : 0.00% (As of Mar. 2011)


View and export this data going back to 2007. Start your Free Trial

What is Bionoid Pharma EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bionoid Pharma's EBITDA for the three months ended in Mar. 2011 was $-5.66 Mil. Bionoid Pharma's Revenue for the three months ended in Mar. 2011 was $0.00 Mil. Therefore, Bionoid Pharma's EBITDA margin for the quarter that ended in Mar. 2011 was 0.00%.


Bionoid Pharma EBITDA Margin % Historical Data

The historical data trend for Bionoid Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionoid Pharma EBITDA Margin % Chart

Bionoid Pharma Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
EBITDA Margin %
- - - - -

Bionoid Pharma Quarterly Data
Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bionoid Pharma's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bionoid Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionoid Pharma's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bionoid Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bionoid Pharma's EBITDA Margin % falls into.



Bionoid Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bionoid Pharma's EBITDA Margin % for the fiscal year that ended in Dec. 2010 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2010 )/Revenue (A: Dec. 2010 )
=-3.851/0
= %

Bionoid Pharma's EBITDA Margin % for the quarter that ended in Mar. 2011 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2011 )/Revenue (Q: Mar. 2011 )
=-5.664/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionoid Pharma  (OTCPK:BINP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Bionoid Pharma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionoid Pharma (Bionoid Pharma) Business Description

Traded in Other Exchanges
N/A
Address
433 N Camden Dr, Beverly Hills, CA, USA, 90210
Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.